GRANDI, Paola
 Distribuzione geografica
Continente #
NA - Nord America 1.256
EU - Europa 206
AS - Asia 190
Continente sconosciuto - Info sul continente non disponibili 2
OC - Oceania 1
SA - Sud America 1
Totale 1.656
Nazione #
US - Stati Uniti d'America 1.256
CN - Cina 129
UA - Ucraina 80
GB - Regno Unito 38
TR - Turchia 38
DE - Germania 33
SG - Singapore 20
IT - Italia 18
FI - Finlandia 17
BE - Belgio 12
RO - Romania 4
A2 - ???statistics.table.value.countryCode.A2??? 2
SE - Svezia 2
AU - Australia 1
BR - Brasile 1
IN - India 1
JP - Giappone 1
MD - Moldavia 1
RU - Federazione Russa 1
SA - Arabia Saudita 1
Totale 1.656
Città #
Fairfield 206
Woodbridge 151
Ann Arbor 132
Houston 125
Jacksonville 92
Seattle 85
Wilmington 74
Ashburn 66
Cambridge 66
Chandler 50
Beijing 35
Izmir 22
Nanjing 21
San Diego 21
Princeton 17
Singapore 13
Boardman 12
Brussels 12
Shanghai 12
Shenyang 11
Changsha 8
New York 8
Falls Church 7
Jiaxing 7
Hebei 5
Nanchang 5
Zhengzhou 5
Auburn Hills 4
Ferrara 4
Mountain View 4
Norwalk 4
Taizhou 4
Jinan 3
Los Angeles 3
Ningbo 3
Redwood City 3
Tianjin 3
Bologna 2
Chicago 2
Dearborn 2
Genoa 2
Hangzhou 2
London 2
Milan 2
Orange 2
Prescot 2
Andover 1
Brasov 1
Changchun 1
Chisinau 1
Fuzhou 1
Guardiagrele 1
Hefei 1
Hounslow 1
Hunedoara 1
Hyderabad 1
Indiana 1
Islington 1
Kunming 1
Leawood 1
Lishui 1
New Bedfont 1
Redmond 1
San Mateo 1
São João del Rei 1
Tappahannock 1
Tokyo 1
Vasto 1
Verona 1
Walnut 1
Totale 1.345
Nome #
Targeting HSV amplicon vectors. 117
Novel mutations in gB and gH circumvent the requirement for known gD Receptors in herpes simplex virus 1 entry and cell-to-cell spread. 113
Generation of herpesvirus entry mediator (HVEM)-restricted herpes simplex virus type 1 mutant viruses: resistance of HVEM-expressing cells and identification of mutations that rescue nectin-1 recognition. 110
HSV-1 amplicon peptide display vector. 105
null 104
Targeting HSV-1 virions for specific binding to epidermal growth factor receptor-vIII-bearing tumor cells. 102
Mice genetic immunization with plasmid DNA encoding a secreted form of HSV-1 gB induces a protective immune response against herpes simplex virus type 1 infection 101
A double mutation in glycoprotein gB compensates for ineffective gD-dependent initiation of herpes simplex virus type 1 infection. 100
Degradation of fibrillar collagen in a human melanoma xenograft improves the efficacy of an oncolytic herpes simplex virus vector. 97
Inhibition of Indoleamine-2,3-dioxygenase (IDO) in Glioblastoma Cells by Oncolytic Herpes Simplex Virus. 97
Ectopic matrix metalloproteinase-9 expression in human brain tumor cells enhances oncolytic HSV vector infection. 96
Use of miRNA Response Sequences to Block Off-target Replication and Increase the Safety of an Unattenuated, Glioblastoma-targeted Oncolytic HSV. 94
Equine herpesvirus type 1 (EHV-1) utilizes microtubules, dynein, and ROCK1 to productively infect cells. 93
Chk2 is required for HSV-1 ICP0-mediated G2/M arrest and enhancement of virus growth. 92
Virus erpetici come vettori vaccinali 84
null 80
null 38
Expression of human immunodeficiency virus type 1 tat from a replication-deficient herpes simplex type 1 vector induces antigen-specific T cell responses 17
Nuovi approcci per lo sviluppo di un vaccino anti-HSV-1: applicazione ed efficacia dell'immunizzazione genetica e/o perioculare basate sulla gB1s nel coniglio 17
Effective treatment of an orthotopic xenograft model of human glioblastoma using an EGFR-retargeted oncolytic herpes simplex virus 16
Totale 1.673
Categoria #
all - tutte 6.524
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 6.524


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020407 0 20 15 68 38 46 38 51 34 39 43 15
2020/2021229 19 22 16 26 7 31 4 32 5 31 22 14
2021/2022228 16 19 38 2 8 8 12 10 8 17 14 76
2022/2023142 18 3 6 12 29 27 0 9 23 3 9 3
2023/202474 11 16 3 5 5 8 0 0 0 1 0 25
2024/202510 9 1 0 0 0 0 0 0 0 0 0 0
Totale 1.673